Dubai, UAE: Around 4,500 cases of cancer are reported in a year in the UAE and the country aims to bring down cancer fatalities to nearly 18 per cent by 2021. Reducing the number of deaths due to prostate cancer is one of the key performance indicators of the pillar of world-class health care of the UAE National Agenda. This was a key topic at a recently held panel discussion that focused on management of prostate cancer patients held by Emirates Urological Society.
The panel discussion witnessed the presence of several key experts. Moderating the panel discussion was Dr Humaid Al Shamsi, President of Emirates Oncology Society (EOS). He was joined by other experts including Dr Neal Shone, Dr Jawaher Ali Ansari and Dr Yasser Farhat.
“Early detection is key to managing prostate cancer. When the disease is in its initial stages (0-II), less aggressive treatment is needed, and the survival rate is almost 100 percent. However, if left undetected and allowed to progress to other areas in the body, the five-year survival rate drops significantly to 30 percent,” said Dr Shamsi.
Elaborating on the need to increase awareness about this cancer that affects men, he said, “Every male above the age of 45 must take a prostate-specific antigen (PSA) test. A PSA test is a simple blood test which is used to screen for prostate cancer, helping with early detection.”
At the panel discussion, panellists were offered an opportunity to hear directly from patients of prostate cancers. The summit focused on the often-overlooked emotional burden of the disease, with the aim of allowing the parties to establish a needs-based support programme to address ways of improving cancer patients’ day-to-day quality of life.
In addition, the discussion also highlighted UAE’s efforts in introducing advanced technology to treat cancer, as well as brought to focus latest trends, enhanced facilities and deployment of experts by the UAE which has been a key force in aiding patients with the right treatment.
Symptoms of prostate cancer usually appear during the late stages of the disease, as such experts at the panel encouraged a screening via genetic testing for men with a strong family history of cancer - such as prostate, breast, pancreatic or colon cancer - in order to better understand their risk.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.